Literature DB >> 3491731

c-myc-induced lymphomagenesis in transgenic mice and the role of the Pvt-1 locus in lymphoid neoplasia.

J M Adams, A W Harris, W Y Langdon, C A Pinkert, R L Brinster, R D Palmiter, L Corcoran, W S Alexander, M W Graham, S Cory.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3491731     DOI： 10.1007/978-3-642-71562-4_1

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  5 in total

1.  Suppression of Myc oncogenic activity by nucleostemin haploinsufficiency.

Authors:  A K Zwolinska; A Heagle Whiting; C Beekman; J M Sedivy; J-C Marine
Journal:  Oncogene       Date:  2011-11-14       Impact factor: 9.867

2.  Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice.

Authors:  Myung-Soo Kang; Hongxiang Lu; Teruhito Yasui; Arlene Sharpe; Henry Warren; Ellen Cahir-McFarland; Roderick Bronson; Siu Chun Hung; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-07       Impact factor: 11.205

3.  Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J mice.

Authors:  Myung-Soo Kang; Vishal Soni; Roderick Bronson; Elliott Kieff
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

4.  Expression of the 6C3 antigen on murine hematopoietic neoplasms. Association with expression of abl, ras, fes, src, erbB, and Cas NS-1 oncogenes but not with myc.

Authors:  H C Morse; G F Tidmarsh; K L Holmes; T F Frederickson; J N Hartley; J H Pierce; W Y Langdon; M O Dailey; I L Weissman
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

5.  Mitochondrial protection impairs BET bromodomain inhibitor-mediated cell death and provides rationale for combination therapeutic strategies.

Authors:  E Lasorsa; M Smonksey; J S Kirk; S Rosario; F J Hernandez-Ilizaliturri; L Ellis
Journal:  Cell Death Dis       Date:  2015-12-10       Impact factor: 8.469
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.